Birdwatch Archive

Birdwatch Note Rating

2023-04-21 22:14:54 UTC - NOT_HELPFUL

Rated by Participant: 29E7B9C7E1F6EDAFFF7A01379537C5F6063ED157BFAB089479F6312AF9C14FB6
Participant Details

Original Note:

Ivermectin tablets are approved by the FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms. Randomized controlled trials show Ivermectin does not have efficacy in COVID-19, cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://www.reuters.com/article/factcheck-nobel-ivermectin/fact-check-2015-nobel-prize-for-ivermectin-intended-for-treatment-of-parasitic-infections-doesnt-prove-its-efficacy-on-covid-19-idUSL1N2QB2XA https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662

All Note Details

Original Tweet

All Information

  • noteId - 1649444853502164997
  • participantId -
  • raterParticipantId - 29E7B9C7E1F6EDAFFF7A01379537C5F6063ED157BFAB089479F6312AF9C14FB6
  • createdAtMillis - 1682115294901
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 164944485350216499729E7B9C7E1F6EDAFFF7A01379537C5F6063ED157BFAB089479F6312AF9C14FB6